Prestige Consumer Healthcare Inc. revenue by segment PBH

Prestige Consumer Healthcare Inc. splits its revenue into 3 lines in its filings. The largest line in fiscal 2026, which ended Mar 31, 2026 was North American OTC Healthcare at $913.6 million, 84% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2027
Jun 30, 2026
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
FY 2021
Mar 31, 2021
FY 2020
Mar 31, 2020
FY 2019
Mar 31, 2019
FY 2018
Mar 31, 2018
FY 2017
Mar 31, 2017
Revenue
1,105
1,089
1,138
1,125
1,128
1,087
943
963
976
1,041
882
North American OTC Healthcare
927
-1.4%
share 83.9%
914
-4.8%
share 83.9%
960
+0.2%
share 84.4%
958
-1.6%
share 85.2%
974
+0.6%
share 86.3%
968
+14.0%
share 89.1%
849
-1.2%
share 90.0%
859
-0.4%
share 89.2%
862
-0.7%
share 88.4%
869
share 83.5%
—
International OTC Healthcare
178
-1.2%
share 16.1%
175
-1.5%
share 16.1%
178
+6.4%
share 15.6%
167
+8.5%
share 14.8%
154
+29.4%
share 13.7%
119
+26.5%
share 10.9%
94
-9.3%
share 10.0%
104
+10.8%
share 10.8%
94
+2.0%
share 9.6%
92
share 8.8%
—
Household Cleaning
—
—
—
—
—
—
—
—
20
-75.4%
share 2.0%
81
share 7.7%
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PBH (NYSE)
Fiscal year ends
March 31
Headquarters
Tarrytown, NY
SEC filer status
Large accelerated filer
SEC CIK
1295947
Former names
Prestige Brands Holdings, Inc. (until Aug 10, 2018)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.